OpenURL Connection Search

Select item for more details and to access through your institution.

Correspondence.
Published in:
2002
By:
- Miall, F.;
- Rye, A.;
- Fraser, M.;
- Hunter, A.;
- Snowden, J. A.;
- Corti, P.;
- Urdezo, C.;
- Tagliabue, A.;
- Volpe, A. Della;
- Annaloro, C.;
- Tagliaferri, E.;
- Balduzzi, A.;
- Hequet, O.;
- Dumontet, C.;
- Jaafario Corbin, A El;
- Salles, G.;
- Espinouse, D.;
- Arnaud, P.;
- Thieblemont, C.
Publication type:
Letter
Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution.
Published in:
Bone Marrow Transplantation, 1999, v. 23, n. 12, p. 1309, doi. 10.1038/sj.bmt.1701820
By:
- Ketterer, N;
- Sonet, A;
- Dumontet, C;
- Moullet, I;
- Thieblemont, C;
- Espinouse, D;
- Bouafia, F;
- Coiffier, B;
- Salles, G
Publication type:
Article
Reduced progression-free survival in elderly patients receiving intensification with autologous peripheral blood stem cell reinfusion for multiple myeloma.
Published in:
Bone Marrow Transplantation, 1998, v. 21, n. 10, p. 1037, doi. 10.1038/sj.bmt.1701232
By:
- Dumontet, C.;
- Ketterer, N.;
- Espinouse, D.;
- Neidhardt, E.M.;
- Moullet, I.;
- Thieblemont, C.;
- Salles, G.;
- Coiffier, B.
Publication type:
Article
A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors.
Published in:
2000
By:
- Dumontet, C;
- Thieblemont, C;
- Espinouse, D;
- Bouafia, F;
- Hequet, O;
- Salles, G;
- Coiffier, B
Publication type:
journal article
Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin's lymphoma.
Published in:
1999
By:
- Dumontet, C;
- Drai, J;
- Bienvenu, J;
- Berard, E Neidhardt;
- Thieblemont, C;
- Bouafia, F;
- Bayle, F;
- Moullet, I;
- Salles, G;
- Coiffier, B;
- Berard, E N
Publication type:
journal article
Allelic loss of 11q13 as detected by MEN1-FISH is not associated with mutation of the MEN1 gene in lymphoid neoplasms.
Published in:
1999
By:
- Thieblemont, C;
- Pack, S;
- Sakai, A;
- Beaty, M;
- Pak, E;
- Vortmeyer, A O;
- Wellmann, A;
- Zhuang, Z;
- Jaffe, E S;
- Raffeld, M
Publication type:
journal article
Mantle cell lymphoma: a retrospective study of 121 cases.
Published in:
1998
By:
- Samaha, H;
- Dumontet, C;
- Ketterer, N;
- Moullet, I;
- Thieblemont, C;
- Bouafia, F;
- Callet-Bauchu, E;
- Felman, P;
- Berger, F;
- Salles, G;
- Coiffier, B
Publication type:
journal article
Kinetic study of pyrrole polymerization with iron (III) chloride in water.
Published in:
Journal of Applied Polymer Science, 1994, v. 52, n. 13, p. 1867, doi. 10.1002/app.1994.070521304
By:
- Planche, M. F.;
- Thiéblemont, J. C.;
- Mazars, N.;
- Bidan, G.
Publication type:
Article
Primary Thyroid Lymphoma Is a Heterogeneous Disease.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 1, p. 105, doi. 10.1210/jcem.87.1.8156
By:
- THIEBLEMONT, C.;
- MAYER, A.;
- DUMONTET, C.;
- BARBIER, Y.;
- CALLET-BAUCHU, E.;
- FELMAN, P.;
- BERGER, F.;
- DUCOTTET, X.;
- MARTIN, C.;
- SALLES, G.;
- ORGIAZZI, J.;
- COIFFIER, B.
Publication type:
Article
Hématologie maligne, Chicago 2012.
Published in:
Oncologie (Tech Science Press), 2012, v. 14, n. 8, p. 478, doi. 10.1007/s10269-012-2189-y
By:
- Mounier, N.;
- Thieblemont, C.
Publication type:
Article
Classifications moléculaires des lymphomes par analyses d’expression génique à haut débit.
Published in:
Oncologie (Tech Science Press), 2006, v. 8, n. 4, p. 314, doi. 10.1007/s10269-006-0389-z
By:
- Thieblemont, C.;
- Xerri, L.
Publication type:
Article
Recovery of central memory and naive peripheral T cells in Follicular Lymphoma patients receiving rituximab-chemotherapy based regimen.
Published in:
Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-50029-y
By:
- Milcent, B.;
- Josseaume, N.;
- Petitprez, F.;
- Riller, Q.;
- Amorim, S.;
- Loiseau, P.;
- Toubert, A.;
- Brice, P.;
- Thieblemont, C.;
- Teillaud, J.-L.;
- Sibéril, S.
Publication type:
Article
JS1.4 Neurological follow-up of neurotoxicity after CAR T cell therapy in lymphoma patients: A French neurological multi-center survey.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii5, doi. 10.1093/neuonc/noz126.013
By:
- Belin, C;
- Simard, C;
- Santos, A Dos;
- Ayrignac, X;
- Berger, C;
- Cartron, G;
- Gouill, S Le;
- Sesques, P;
- Thieblemont, C;
- Carpentier, A F
Publication type:
Article
Targeting of B-cell receptor signalling in B-cell malignancies.
Published in:
2017
By:
- Jerkeman, M.;
- Hallek, M.;
- Dreyling, M.;
- Thieblemont, C.;
- Kimby, E.;
- Staudt, L.
Publication type:
journal article
A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases.
Published in:
Histopathology, 2006, v. 48, n. 2, p. 162, doi. 10.1111/j.1365-2559.2005.02309.x
By:
- Traverse-Glehen, A.;
- Felman, P.;
- Callet-Bauchu, E.;
- Gazzo, S.;
- Baseggio, L.;
- Bryon, P. A.;
- Thieblemont, C.;
- Coiffier, B.;
- Salles, G.;
- Berger, F.
Publication type:
Article
Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma.
Published in:
Bone Marrow Transplantation, 2004, v. 33, n. 9, p. 921, doi. 10.1038/sj.bmt.1704467
By:
- Lemieux, B.;
- Tartas, S.;
- Traulle, C.;
- Espinouse, D.;
- Thieblemont, C.;
- Bouafia, F.;
- Alhusein, Q.;
- Antal, D.;
- Salles, G.;
- Coiffier, B.
Publication type:
Article
Autoimmune thrombocytopenic purpura after autologous stem cell transplantation.
Published in:
Bone Marrow Transplantation, 2003, v. 32, n. 1, p. 89, doi. 10.1038/sj.bmt.1704073
By:
- Hequet, O;
- Salles, G;
- Ketterer, N;
- Espinouse, D;
- Dumontet, C;
- Thieblemont, C;
- Arnaud, P;
- Bouafia, F;
- Coiffier, B
Publication type:
Article
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.
Published in:
Bone Marrow Transplantation, 2002, v. 30, n. 11, p. 769, doi. 10.1038/sj.bmt.1703757
By:
- Thieblemont, C;
- Dumontet, C;
- Saad, H;
- Roch, N;
- Bouafia, F;
- Arnaud, P;
- Hequet, O;
- Espinouse, D;
- Salles, G;
- Roy, P;
- Eljaafari-Corbin, A;
- du Manoir-Baumgarten, C;
- Coiffier, B
Publication type:
Article
Multifocal progressive leukoencephalopathy occurring after refractory anemia and multiple infectious disorders consecutive to severe lymphopenia.
Published in:
Annals of Hematology, 2002, v. 81, n. 6, p. 340, doi. 10.1007/s00277-002-0458-3
By:
- Hequet, O.;
- Salles, G.;
- Espinousse, D.;
- Dumontet, C.;
- Bouafia, F.;
- Thieblemont, C.;
- Revesz, D.;
- Coiffier, B.
Publication type:
Article
Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d'Etude des Lymphomes de l'Adulte trial.
Published in:
2010
By:
- Rolland D;
- Ribrag V;
- Haioun C;
- Ghesquieres H;
- Jardin F;
- Bouabdallah R;
- Franchi P;
- Briere J;
- De Kerviler E;
- Chassagne-Clement C;
- Raponi M;
- Houlgatte R;
- Jais JP;
- Thieblemont C;
- Rolland, Delphine;
- Ribrag, Vincent;
- Haioun, Corinne;
- Ghesquieres, Herve;
- Jardin, Fabrice;
- Bouabdallah, Reda
Publication type:
journal article
GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-[kappa]B-dependent induction of HIF-1[alpha].
Published in:
2015
By:
- Chiche, J;
- Pommier, S;
- Beneteau, M;
- Mondragón, L;
- Meynet, O;
- Zunino, B;
- Mouchotte, A;
- Verhoeyen, E;
- Guyot, M;
- Pagès, G;
- Mounier, N;
- Imbert, V;
- Colosetti, P;
- Goncalvès, D;
- Marchetti, S;
- Brière, J;
- Carles, M;
- Thieblemont, C;
- Ricci, J-E
Publication type:
Journal Article
GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1α.
Published in:
Leukemia (08876924), 2015, v. 29, n. 5, p. 1163, doi. 10.1038/leu.2014.324
By:
- Chiche, J;
- Pommier, S;
- Beneteau, M;
- Mondragón, L;
- Meynet, O;
- Zunino, B;
- Mouchotte, A;
- Verhoeyen, E;
- Guyot, M;
- Pagès, G;
- Mounier, N;
- Imbert, V;
- Colosetti, P;
- Goncalvès, D;
- Marchetti, S;
- Brière, J;
- Carles, M;
- Thieblemont, C;
- Ricci, J-E
Publication type:
Article
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.
Published in:
Leukemia (08876924), 2008, v. 22, n. 3, p. 487, doi. 10.1038/sj.leu.2405068
By:
- Matutes, E.;
- Oscier, D.;
- Montalban, C.;
- Berger, F.;
- Callet-Bauchu, E.;
- Dogan, A.;
- Felman, P.;
- Franco, V.;
- Iannitto, E.;
- Mollejo, M.;
- Papadaki, T.;
- Remstein, E. D.;
- Salar, A.;
- Solé, F.;
- Stamatopoulos, K.;
- Thieblemont, C.;
- Traverse-Glehen, A.;
- Wotherspoon, A.;
- Coiffier, B.;
- Piris, M. A.
Publication type:
Article
Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin.
Published in:
2007
By:
- Traverse-Glehen, A.;
- Verney, A.;
- Baseggio, L.;
- Felman, P.;
- Callet-Bauchu, E.;
- Thieblemont, C.;
- Ffrench, M.;
- Magaud, J.-P.;
- Coiffier, B.;
- Berger, F.;
- Salles, G.
Publication type:
Letter
Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases.
Published in:
Leukemia (08876924), 2005, v. 19, n. 10, p. 1818, doi. 10.1038/sj.leu.2403909
By:
- Callet-Bauchu, E.;
- Baseggio, L.;
- Felman, P.;
- Traverse-Glehen, A.;
- Berger, F.;
- Morel, D.;
- Gazzo, S.;
- Poncet, C.;
- Thieblemont, C.;
- Coiffier, B.;
- Magaud, J. P.;
- Salles, G.
Publication type:
Article
AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐CELL LYMPHOMA IN TRANSPLANT‐INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 147, doi. 10.1002/hon.3163_97
By:
- Houot, R.;
- Bachy, E.;
- Cartron, G.;
- Gros, F.;
- Morschhauser, F.;
- Oberic, L.;
- Gastinne, T.;
- Feugier, P.;
- Dulery, R.;
- Thieblemont, C.;
- Joris, M.;
- Jardin, F.;
- Choquet, S.;
- Casasnovas, O.;
- Brisou, G.;
- Cheminant, M.;
- Bay, J.;
- Gutierrez, F. Llamas;
- Menard, C.;
- Tarte, K.
Publication type:
Article
NATHALI‐01: A PHASE 1/2A TRIAL OF UCART20X22, AN ALLOGENEIC DUAL CAR T‐CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA (NHL).
Published in:
Hematological Oncology, 2023, v. 41, p. 825, doi. 10.1002/hon.3166_OT08
By:
- Bachy, E.;
- Ramakrishnan, A.;
- Thieblemont, C.;
- Alfonso, A.;
- Braunschweig, I.;
- Riedell, P. A.;
- Cartron, G.;
- Barba, P.;
- Gastinne, T.;
- Simon, J. A. Perez;
- Solano, C.;
- Meadows, S.;
- LaCroce, A.;
- Thomas, D.;
- Poirot, C.;
- Newhall, K. J.;
- Lee, D. J.;
- Frattini, M. G.;
- Abramson, J.
Publication type:
Article
SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA: LONGER FOLLOW‐UP FROM THE PIVOTAL EPCORE NHL‐1 TRIAL.
Published in:
Hematological Oncology, 2023, v. 41, p. 142, doi. 10.1002/hon.3163_94
By:
- Thieblemont, C.;
- Karimi, Y.;
- Jurczak, W.;
- Cheah, C. Y.;
- Clausen, M. R.;
- Cunningham, D.;
- Do, Y. R.;
- Lewis, D. J.;
- Gasiorowski, R.;
- Kim, T. M.;
- van der Poel, M.;
- Poon, M. L.;
- Feldman, T.;
- Linton, K. M.;
- Sureda, A.;
- Hutchings, M.;
- Cottereau, A.;
- Al Tabaa, Y.;
- Stirner, M. Cota;
- Liu, Y.
Publication type:
Article
RITUXIMAB AND IBRUTINIB COMBINATION IS SAFE AND EFFECTIVE IN UNTREATED SPLENIC AND NODAL MARGINAL ZONE LYMPHOMAS: PLANNED SUBSET ANALYSIS OF THE IELSG47/MALIBU PHASE II STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 104, doi. 10.1002/hon.3163_65
By:
- Thieblemont, C.;
- Lamy, T.;
- Tani, M.;
- Krzisch, D.;
- Reda, G.;
- Tedeschi, A.;
- Usai, S. V.;
- Guarini, A.;
- Bijou, F.;
- Stathis, A.;
- Anastasia, A.;
- Devizzi, L.;
- Luminari, S.;
- Arcaini, L.;
- Casasnovas, O.;
- Gressin, R.;
- André, M.;
- Houot, R.;
- Bonomini, L.;
- Zucca, E.
Publication type:
Article
RISK STRATIFICATION OF DLBCL WITH MVED2 SCORE USING INTEGRATIVE HOST ADIPOSE DENSITY AND METABOLIC TUMOR CHARACTERISTICS COMPARED TO OTHER INDEXES.
Published in:
Hematological Oncology, 2023, v. 41, p. 91, doi. 10.1002/hon.3163_55
By:
- Thieblemont, C.;
- Chartier, L.;
- Vercellino, L.;
- Deux, J.;
- Casasnovas, O.;
- Judet, A.;
- Baud, V.;
- Tilly, H.;
- Cottereau, A.
Publication type:
Article
ROMIDEPSIN PLUS CHOP VERSUS CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED PERIPHERAL T‐CELL LYMPHOMA: FINAL ANALYSIS OF THE RO‐CHOP TRIAL.
Published in:
Hematological Oncology, 2023, v. 41, p. 77, doi. 10.1002/hon.3163_41
By:
- Camus, V.;
- Thieblemont, C.;
- Gaulard, P.;
- Cheminant, M.;
- Casasnovas, R.;
- Ysebaert, L.;
- Damaj, G. L.;
- Guidez, S.;
- Pica, G. M.;
- Kim, W. S.;
- Lim, S. T.;
- Andre, M.;
- Gutiérrez, N.;
- Penarrubia, M. J.;
- Staber, P. B.;
- Trotman, J.;
- Hüttmann, A.;
- Stefoni, V.;
- Rossi, G.;
- Delfau‐Larue, M.
Publication type:
Article
Efficacy of Subcutaneous Epcoritamab versus Axi‐cel in R/R DLBCL CAR T‐Naive and CAR T‐eligible patients: An Indirect Comparison.
Published in:
Hematological Oncology, 2023, v. 41, p. 453, doi. 10.1002/hon.3164_334
By:
- Thieblemont, C.;
- Fox, C. P.;
- Wang, A.;
- Sail, K.;
- Alshreef, A.;
- Moran, M.;
- Mutebi, A.;
- Blaedel, J.;
- Chirikov, V.;
- Salles, G.
Publication type:
Article
Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR).
Published in:
Hematological Oncology, 2023, v. 41, p. 437, doi. 10.1002/hon.3164_322
By:
- Fornecker, L.;
- Delwail, V.;
- Thieblemont, C.;
- Ghesquieres, H.;
- Bouabdallah, K.;
- Tilly, H.;
- Le Calloch, R.;
- Morschhauser, F.;
- Costello, R.;
- Slama, B.;
- Gyan, E.;
- Chauchet, A.;
- Ngirabacu, M.;
- Durot, E.;
- Choquet, S.;
- Capdupuy, C.;
- Le Goff, M.;
- Voillat, L.;
- Snauwaert, S.;
- Amorim, S.
Publication type:
Article
Cause of death and prognosis of patients (pts) with primary refractory disease, and prognosis of pts reaching PFS24: Descriptive analysis of POLARIX.
Published in:
Hematological Oncology, 2023, v. 41, p. 432, doi. 10.1002/hon.3164_318
By:
- Herbaux, C.;
- Dietrich, S.;
- McMillan, A.;
- Thieblemont, C.;
- Gonzalez‐Barca, E.;
- Pinto, A.;
- Fogliatto, L.;
- Matasar, M.;
- Lee, C.;
- Hernandez, J.;
- Hirata, J.;
- Ho, R.;
- Launonen, A.;
- Boissard, F.
Publication type:
Article
Long‐term efficacy and safety of zanubrutinib (ZANU) in relapsed/refractory marginal zone lymphoma (R/R MZL): final analysis of the MAGNOLIA (BGB‐3111‐214) trial.
Published in:
Hematological Oncology, 2023, v. 41, p. 390, doi. 10.1002/hon.3164_284
By:
- Trotman, J.;
- Tedeschi, A.;
- Hu, B.;
- Linton, K. M.;
- McKay, P.;
- Leitch, S.;
- Jin, J.;
- Sun, M.;
- Sobieraj‐Teague, M.;
- Zinzani, P. L.;
- Browett, P.;
- Thieblemont, C.;
- Liberati, A. M.;
- Bachy, E.;
- Cavallo, F.;
- Costello, R.;
- Iyengar, S.;
- Marasca, R.;
- Mociková, H.;
- Kim, J. S.
Publication type:
Article
Matching‐adjusted indirect comparison (MAIC) of zanubrutinib (ZANU) versus ibrutinib (IBRU) in relapsed/refractory marginal zone lymphoma (R/R MZL).
Published in:
Hematological Oncology, 2023, v. 41, p. 388, doi. 10.1002/hon.3164_282
By:
- Thieblemont, C.;
- Wang, K.;
- Keeping, S.;
- Zhang, I.;
- Yang, K.;
- Tang, B.;
- Mohseninejad, L.
Publication type:
Article
Evaluation of ctDNA in a phase I/II trial in relapsed or refractory large B‐cell lymphoma of epcoritamab, a novel, subcutaneous CD3xCD20 bispecific T‐cell–engaging antibody.
Published in:
Hematological Oncology, 2023, v. 41, p. 326, doi. 10.1002/hon.3164_232
By:
- Soong, D.;
- Thieblemont, C.;
- Karavitis, J.;
- Hess, B.;
- Caimi, P.;
- Feldman, T.;
- Hutchings, M.;
- Sureda, A.;
- Szafer‐Glusman, E.;
- Sacchi, M.;
- Jure‐Kunkel, M.;
- Adya, N.;
- Chiu, C.
Publication type:
Article
Prognostic Value of Lymphopenia and Total Metabolic Tumor Volume in Diffuse Large Cell Lymphoma of B Phenotype in the RT3 and REMARC trials—A LYSA retrospective analysis.
Published in:
Hematological Oncology, 2023, v. 41, p. 346, doi. 10.1002/hon.3164_248
By:
- Willaume, A.;
- Chartier, L.;
- Ricci, R.;
- Blanc‐Durand, P.;
- Amorim, S.;
- Haioun, C.;
- Thieblemont, C.;
- Legouill, S.;
- Casasnovas, O.;
- Morschhauser, F.;
- Jardin, F.;
- Pascal, L.
Publication type:
Article
VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 151, doi. 10.1002/hon.3163_100
By:
- Sarkozy, C.;
- Thieblemont, C.;
- Oberic, L.;
- Moreau, A.;
- Bouabdallah, K.;
- Damaj, G.;
- Gastine, T.;
- Ribrag, V.;
- Casasnovas, O.;
- Haioun, C.;
- Houot, R.;
- Jardin, F.;
- Van Den Neste, E.;
- Cheminant, M.;
- Morschhauser, F.;
- Callana, M.;
- Ghesquieres, H.;
- Gressin, R.;
- Hermine, O.;
- Le Gouill, S.
Publication type:
Article
LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLINE R‐CHOP: UPDATE OF THE LNH03‐6B TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.96_2880
By:
- Camus, V.;
- Belot, Aurél.;
- Oberic, L.;
- Sibon, D.;
- Ghesquières, H.;
- Thieblemont, C.;
- Fruchart, C.;
- Casasnovas, O.;
- Michot, Jean‐M.;
- Molina, T. J.;
- Bosly, A.;
- Joubert, Clém.;
- Haioun, C.;
- Delarue, R.;
- Tilly, H.
Publication type:
Article
SELINEXOR IN COMBINATION WITH R‐GDP FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE SELINDA PHASE IB LYSA STUDY (EUDRACT NUMBER: 2015‐005612‐15)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.88_2880
By:
- Maerevoet, M.;
- Casasnovas, O.;
- Cartron, G.;
- Morschhauser, F.;
- Thieblemont, C.;
- Bouabdallah, K.;
- Feugier, P.;
- Szablewski, V.;
- Becker, S.;
- Tilly, H.
Publication type:
Article
SELINEXOR IN COMBINATION WITH R‐GDP FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE SELINDA PHASE IB LYSA STUDY (EUDRACT NUMBER: 2015‐005612‐15)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.87_2880
By:
- Maerevoet, M.;
- Casasnovas, O.;
- Cartron, G.;
- Morschhauser, F.;
- Thieblemont, C.;
- Bouabdallah, K.;
- Feugier, P.;
- Szablewski, V.;
- Becker, S.;
- Tilly, H.
Publication type:
Article
EFFICACY AND SAFETY OF TISAGENLECLEUCEL (TISA‐CEL) IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): PRIMARY ANALYSIS OF THE PHASE 2 ELARA TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.85_2879
By:
- Schuster, S. J.;
- Dickinson, M.;
- Dreyling, M.;
- Martinez‐Lopez, J.;
- Kolstad, A.;
- Butler, J.;
- Ghosh, M.;
- Popplewell, L.;
- Chavez, J. C.;
- Bachy, E.;
- Kato, K.;
- Harigae, H.;
- Kersten, M. José;
- Andreadis, C.;
- Riedell, P. A.;
- Abdelhady, A.;
- Zia, A.;
- Morisse, M. C.;
- Fowler, N. H.;
- Thieblemont, C.
Publication type:
Article
HIGH ADIPOSE TISSUE DENSITY IS A NEGATIVE PROGNOSTIC FACTOR IN DLBCL PATIENTS TREATED BY R‐CHOP, INDEPENDENT FROM TMTV AND PS –FROM THE REMARC STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.78_2880
By:
- Deux, J.‐F.;
- Meignan, M.;
- Chartier, L.;
- Judet, A.;
- Vercellino, L.;
- Casasnovas, O.;
- Baud, V.;
- Tilly, H.;
- Cottereau, A.‐S.;
- Thieblemont, C.
Publication type:
Article
HIGH‐RISK MANTLE CELL LYMPHOMA IN THE LYMA TRIAL: A LYSA STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.64_2880
By:
- Cheminant, M.;
- Burroni, B.;
- Le Bris, Y.;
- Chartier, L.;
- Oberic, L.;
- Ribrag, V.;
- Delfau, M.‐H.;
- Thieblemont, C.;
- Gressin, R.;
- Canioni, D.;
- Peyre, M.;
- Laurent, C.;
- Steimle, T.;
- Kaltenbach, S.;
- Asnafi, V.;
- Macintyre, E.;
- Callanan, M.;
- Le Gouill, S.;
- Hermine, O.
Publication type:
Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.57_2880
By:
- Herbaux, C.;
- Schiano de Colella, J. M.;
- Thieblemont, C.;
- Guidez, S.;
- Ysebaert, L.;
- Tilly, H.;
- Le Gouill, S.;
- Houot, R.;
- Bachy, E.;
- Laurent, C.;
- Damaj, G.;
- Feugier, P.;
- Morineau, N.;
- Tarte, K.;
- Morschhauser, F.;
- Cartron, G.
Publication type:
Article
EARLY POSITRON EMISSION TOMOGRAPHY RESPONSE‐ADAPTED TREATMENT IN LOCALIZED DIFFUSE LARGE B‐CELL LYMPHOMA (AAIPI=0) : RESULTS OF THE PHASE 3 LYSA LNH 09‐1B TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.5_2879
By:
- Bologna, S;
- Vander Borght, T;
- Briere, J;
- Ribrag, V;
- Damaj, G. L;
- Thieblemont, C;
- Feugier, P;
- Peyrade, F;
- Lebras, L;
- Coso, D;
- Sibon, D;
- Bonnet, C;
- Morschhauser, F;
- Ghesquieres, H;
- Becker, S;
- Olivier, P;
- Fabiani, B;
- Tilly, H;
- Haioun, C;
- Bastie, J. N
Publication type:
Article
ENDPOINTS IN MARGINAL ZONE LYMPHOMAS: A SYSTEMATIC REVIEW REVEALS WIDE HETEROGENEITY ACROSS TRIALS AND CALLS FOR STANDARDIZATION.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.27_2881
By:
- Bommier, C;
- Ruggiu, M;
- Monegier, A;
- Zucca, E;
- Thieblemont, C;
- Lambert, J
Publication type:
Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.22_2880
By:
- Cartron, G.;
- Bachy, E.;
- Guidez, S.;
- Gyan, E.;
- Gressin, R.;
- Morineau, N.;
- Sibon, D.;
- Casasnovas, O.;
- Le Gouill, S.;
- Tilly, H.;
- Ysebaert, L.;
- Schiano de Colella, J. M.;
- Feugier, P.;
- Virelizier, E. Nicolas;
- Haioun, C.;
- Damaj, G.;
- Tarte, K.;
- Laurent, C.;
- Houot, R.;
- Thieblemont, C.
Publication type:
Article
SAFETY AND EFFICACY OF ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (MAGNOLIA PHASE 2 STUDY)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.19_2880
By:
- Trotman, J.;
- Tedeschi, A.;
- Linton, K.;
- McKay, P.;
- Hu, B.;
- Chan, H.;
- Jin, J.;
- Sobieraj‐Teague, M.;
- Zinzani, P. L.;
- Coleman, M.;
- Browett, P.;
- Ke, X.;
- Sun, M.;
- Marcus, R.;
- Portell, C.;
- Thieblemont, C.;
- Zhou, K.;
- Liberati, A. M.;
- Bachy, E.;
- Cavallo, F.
Publication type:
Article

Found: 80